About Option Care Health, Inc. - Common Stock (OPCH)
Option Care Health Inc is a leading provider of home and alternate site infusion services in the United States. The company specializes in delivering personalized intravenous (IV) medication therapies to patients in the comfort of their homes or in outpatient settings, focusing on critical care, oncology, and infectious diseases. Through a network of experienced healthcare professionals, Option Care Health ensures high-quality patient care and treatment, while also emphasizing collaboration with healthcare providers to improve health outcomes and enhance the overall patient experience. The company aims to be a trusted partner in the healthcare continuum, offering innovative solutions tailored to individual patient needs. Read More
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per share.
What Happened? Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 33.2% in the pre-market session after Financial Times reporte...
BALA CYNWYD, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the transaction, CD&R will hold a majority ownership interest, and McKesson will hold a minority ownership interest. Option Care Health will remain a separate company led by its own management team.
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Over the last six months, Option Care Health’s shares have sunk to $23.95, producing a disappointing 15.7% loss - a stark contrast to the S&P 500’s 16.2% gai...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Option Care Health (NASDAQ:O...
BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences:
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Option Care Health’s second quarter was marked by continued operational execution, driving results that exceeded Wall Street’s expectations and prompted a si...
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 1.9% year on...
